CY1119983T1 - Μεθοδος για παραγωγη ενωσης 4,4,7-τριφθορο-1,2,3,4-τετραϋδρο-5η-1-βενζαζεπινης και ενδιαμεσου προϊοντος για συνθεση εξ' αυτης - Google Patents
Μεθοδος για παραγωγη ενωσης 4,4,7-τριφθορο-1,2,3,4-τετραϋδρο-5η-1-βενζαζεπινης και ενδιαμεσου προϊοντος για συνθεση εξ' αυτηςInfo
- Publication number
- CY1119983T1 CY1119983T1 CY20181100092T CY181100092T CY1119983T1 CY 1119983 T1 CY1119983 T1 CY 1119983T1 CY 20181100092 T CY20181100092 T CY 20181100092T CY 181100092 T CY181100092 T CY 181100092T CY 1119983 T1 CY1119983 T1 CY 1119983T1
- Authority
- CY
- Cyprus
- Prior art keywords
- production
- tetrahydro
- trifthoro
- benzazepein
- compound
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- WGQWRLLENSTDAH-UHFFFAOYSA-N 4,4,7-trifluoro-1,2,3,5-tetrahydro-1-benzazepine Chemical compound N1CCC(F)(F)CC2=CC(F)=CC=C21 WGQWRLLENSTDAH-UHFFFAOYSA-N 0.000 abstract 1
- 239000004475 Arginine Substances 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 206010036018 Pollakiuria Diseases 0.000 abstract 1
- 208000004880 Polyuria Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 102000002852 Vasopressins Human genes 0.000 abstract 1
- 108010004977 Vasopressins Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000035619 diuresis Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 206010029446 nocturia Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000022934 urinary frequency Diseases 0.000 abstract 1
- 230000036318 urination frequency Effects 0.000 abstract 1
- 229960003726 vasopressin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012131504 | 2012-06-11 | ||
| PCT/JP2013/066076 WO2013187406A1 (ja) | 2012-06-11 | 2013-06-11 | 4,4,7-トリフルオロ-1,2,3,4-テトラヒドロ-5h-1-ベンゾアゼピン化合物の製造方法及びその合成中間体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1119983T1 true CY1119983T1 (el) | 2018-12-12 |
Family
ID=49758228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20181100092T CY1119983T1 (el) | 2012-06-11 | 2018-01-24 | Μεθοδος για παραγωγη ενωσης 4,4,7-τριφθορο-1,2,3,4-τετραϋδρο-5η-1-βενζαζεπινης και ενδιαμεσου προϊοντος για συνθεση εξ' αυτης |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US9598373B2 (enExample) |
| EP (1) | EP2860175B1 (enExample) |
| JP (2) | JPWO2013187406A1 (enExample) |
| CY (1) | CY1119983T1 (enExample) |
| DK (1) | DK2860175T3 (enExample) |
| ES (1) | ES2659180T3 (enExample) |
| HR (1) | HRP20180032T8 (enExample) |
| HU (1) | HUE035391T2 (enExample) |
| LT (1) | LT2860175T (enExample) |
| NO (1) | NO2860175T3 (enExample) |
| PL (1) | PL2860175T3 (enExample) |
| PT (1) | PT2860175T (enExample) |
| RS (1) | RS56804B1 (enExample) |
| SI (1) | SI2860175T1 (enExample) |
| SM (1) | SMT201800106T1 (enExample) |
| WO (1) | WO2013187406A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX362478B (es) * | 2012-12-26 | 2019-01-11 | Sanwa Kagaku Kenkyusho Co | Derivado de benzoazepina novedoso y uso medico del mismo. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2857760B2 (ja) * | 1989-02-17 | 1999-02-17 | 第一製薬株式会社 | プロポキシニトロベンゼン類の製法 |
| CA2263267C (en) * | 1996-09-18 | 2006-05-02 | Daiso Co., Ltd. | Process for the preparation of glycidyl ethers |
| MXPA04004501A (es) | 2001-11-16 | 2004-08-11 | Yamanouchi Pharma Co Ltd | Derivados de 4-4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o sales de los mismos. |
| ATE512951T1 (de) * | 2003-04-28 | 2011-07-15 | Astellas Pharma Inc | 4,4-difluor-1,2,3,4-tetrahydro-5h-1- benzazepinderivat oder salz davon |
| CA2570688A1 (en) | 2004-06-24 | 2006-02-02 | Eli Lilly And Company | Compounds and methods for treating dyslipidemia |
| JP4765546B2 (ja) | 2004-10-27 | 2011-09-07 | アステラス製薬株式会社 | ベンゾアゼピン誘導体又はその塩の製造法 |
| JP4765545B2 (ja) | 2004-10-27 | 2011-09-07 | アステラス製薬株式会社 | ベンゾアゼピン誘導体を有効成分とする医薬組成物 |
| EP2235988B1 (en) * | 2008-02-01 | 2011-11-30 | Interdigital Patent Holdings, Inc. | Method and apparatus for enabling cell reselection for wtru operating in discontinuous reception |
-
2013
- 2013-06-11 NO NO13804693A patent/NO2860175T3/no unknown
- 2013-06-11 SI SI201330925T patent/SI2860175T1/en unknown
- 2013-06-11 US US14/406,568 patent/US9598373B2/en not_active Expired - Fee Related
- 2013-06-11 RS RS20180081A patent/RS56804B1/sr unknown
- 2013-06-11 JP JP2014521349A patent/JPWO2013187406A1/ja not_active Ceased
- 2013-06-11 HU HUE13804693A patent/HUE035391T2/en unknown
- 2013-06-11 EP EP13804693.3A patent/EP2860175B1/en active Active
- 2013-06-11 ES ES13804693.3T patent/ES2659180T3/es active Active
- 2013-06-11 DK DK13804693.3T patent/DK2860175T3/da active
- 2013-06-11 PT PT138046933T patent/PT2860175T/pt unknown
- 2013-06-11 WO PCT/JP2013/066076 patent/WO2013187406A1/ja not_active Ceased
- 2013-06-11 LT LTEP13804693.3T patent/LT2860175T/lt unknown
- 2013-06-11 SM SM20180106T patent/SMT201800106T1/it unknown
- 2013-06-11 PL PL13804693T patent/PL2860175T3/pl unknown
- 2013-06-11 HR HRP20180032TT patent/HRP20180032T8/hr unknown
-
2017
- 2017-02-16 US US15/434,678 patent/US9951022B2/en not_active Expired - Fee Related
-
2018
- 2018-01-24 CY CY20181100092T patent/CY1119983T1/el unknown
- 2018-03-23 US US15/933,804 patent/US10508084B2/en not_active Expired - Fee Related
- 2018-08-15 JP JP2018152818A patent/JP2019014716A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2013187406A1 (ja) | 2016-02-04 |
| ES2659180T3 (es) | 2018-03-14 |
| HUE035391T2 (en) | 2018-05-02 |
| RS56804B1 (sr) | 2018-04-30 |
| DK2860175T3 (da) | 2018-01-29 |
| PL2860175T3 (pl) | 2018-07-31 |
| SMT201800106T1 (it) | 2018-03-08 |
| HRP20180032T8 (hr) | 2018-12-14 |
| NO2860175T3 (enExample) | 2018-04-28 |
| WO2013187406A1 (ja) | 2013-12-19 |
| PT2860175T (pt) | 2018-02-02 |
| EP2860175A1 (en) | 2015-04-15 |
| SI2860175T1 (en) | 2018-04-30 |
| US9951022B2 (en) | 2018-04-24 |
| LT2860175T (lt) | 2018-03-26 |
| US10508084B2 (en) | 2019-12-17 |
| US20150141641A1 (en) | 2015-05-21 |
| EP2860175A4 (en) | 2015-12-09 |
| EP2860175B1 (en) | 2017-11-29 |
| HRP20180032T1 (hr) | 2018-03-23 |
| US20190062280A1 (en) | 2019-02-28 |
| US9598373B2 (en) | 2017-03-21 |
| US20170158639A1 (en) | 2017-06-08 |
| JP2019014716A (ja) | 2019-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119252T1 (el) | Νεα παραγωγα 1-βενζυλο-3 -υδροξυμεθυλινδαζολης και χρηση αυτων στη θεραπεια νοσων που βασιζονται στην εκφραση των cx3cr1 και ρ40 | |
| CR20130259A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| UY32574A (es) | Antagonistas del receptor cxcr3 | |
| CY1119170T1 (el) | Ενωση γουανιδινης | |
| CL2017000830A1 (es) | Formulación estable que comprende un azúcar no reductora, un anticuerpo anti-s4b7 y al menos un aminoácido libre; un método para preparar dicha formulación; uso de dicha formulación para tratar una enfermedad inflamatoria del intestino. | |
| CY1116892T1 (el) | Ενωσεις οι οποιες εχουν δραστικοτητα ανταγωνιστη μουσκαρινικου υποδοχεα και αγωνιστη βητα2 αδρενεργικου υποδοχεα | |
| CO6382155A2 (es) | Agonistas del receptor gpr120 de arilo y usos de los mismos | |
| ECSP13012611A (es) | Derivados de pirazol-aminopirimidina como moduladores de la lrrk2 | |
| HN2012001351A (es) | Derivados de 3- hidroxi-5-arilisotiazol novedosos | |
| MX2020005738A (es) | Derivados de glutarimida, uso de los mismos, composicion farmaceutica basada en los mismos y metodos para producir derivados de glutarimida. | |
| GT201300253A (es) | Preparacion de gadobutrol de alta pureza | |
| CY1119798T1 (el) | Μορφη iv υδροχλωρικης ιβαμπραδινης | |
| ATE538100T1 (de) | Aminotetrahydroindazoloessigsäuren | |
| CY1117416T1 (el) | Παραγωγα βενζαζολης ως προσδετες του υποδοχεα ισταμινης η4 | |
| AR079945A1 (es) | Derivados de pirazina como inhibidores de glucogeno sintasa quinasa 3 (gsk3) | |
| CL2011001405A1 (es) | Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina. | |
| EA201290077A1 (ru) | Соединения-801 | |
| EA201291014A1 (ru) | Трициклическое индазольное соединение, способ его получения и содержащая его фармацевтическая композиция | |
| UA107702C2 (xx) | Похідні бензаміду | |
| AR081514A1 (es) | El compuesto 4-[etil(dimetil)amonio]butanoato, el metodo para la preparacion del mismo y el uso en el tratamiento de la enfermedad cardiovascular | |
| CY1119983T1 (el) | Μεθοδος για παραγωγη ενωσης 4,4,7-τριφθορο-1,2,3,4-τετραϋδρο-5η-1-βενζαζεπινης και ενδιαμεσου προϊοντος για συνθεση εξ' αυτης | |
| NZ609596A (en) | Cyclohexane derivative compound | |
| CL2015000708A1 (es) | Compuestos derivados de tert-butil-metil-amida del acido 5-(cloro-(piridin o fenil)-etinil)-piridina-2-carboxilico, como antagonistas de receptores metabotropicos de glutamato; su proceso de obtencion; composicion farmaceutica; y su uso para el tratamiento de ansiedad y dolor, depresion, enfermedad de parkinson, entre otras enfermedades. | |
| MX2013011728A (es) | Nuevos compuestos de benzofurano-piperidina. | |
| CY1118711T1 (el) | Συνδυασμος ( 3s, 3s' )4, 4'-δισουλφανοδιυλοδι (3-αμινοβουτανο 1-σουλφονικου οξεος) και ενος δευτερου αντιυπερτασικου παραγοντα |